As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There By Arthur Allen Oct. 20, 2026

https://kffhealthnews.org/health-industry/china-cancer-drugs-foreign-travel-pharma-biotech-fda-regulation-clinical-trials/?utm_campaign=KHN%3A%20Colorado&utm_medium=email&_hsenc=p2ANqtz-9CawA6-tn1UJbfU3sIOlrZirrEFxHbV5oZ_dC5PFVDT4gcldrfQPRx2NyF-K_3vI_51pDI8h0L0UO8J_GpwlcHVitobA&_hsmi=446375587&utm_content=446375587&utm_source=hs_email As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There By Arthur Allen Americans, Europeans, and others are trekking to China to enter clinical trials for CAR-T therapy, an area in which China is now a world leader. Kyle Concannon, a leader of a University of Colorado research team that has developed a variety of CAR-T therapy, said regulatory uncertainty in the U.S. has slowed his team’s progress.